EGFR/CDK2-IN-4
EGFR/CDK2-IN-4 is a dual-targeting inhibitor with IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK2. It exhibits anti-proliferative activity in MCF-7 breast cancer cells (IC50 = 2.74 μM) by inducing S-phase cell cycle arrest and apoptosis, making it a useful tool for oncology research in vitro.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin; Cell Biology, Signal Transduction
Molecular Formula
C24H16N6OS2
Molecular Weight
468.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog